[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353372-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353372-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","swin-unetr-based-prediction-of-68-gagafapi-46-petct-dose-rate-maps-in-cancer-patients-quantitative-comparison-with-18-ffdg-petct","Swin UNETR-based prediction of [68 Ga]GaFAPI-46 PET/CT dose rate maps in cancer patients - quantitative comparison with [18 F]FDG PET/CT","","Fibroblast activation protein (FAP) is a promising theranostic target because it is highly expressed in the stroma of many malignancies. This study introduces a first deep-learning framework to predict dose rate maps (DRMs) from [68Ga]Ga-FAPI-46 PET/CT, followed by a quantitative dosimetric comparison with [18F]FDG PET/CT. The method supports personalized pre-therapeutic planning for radiopharmaceutical therapies by enabling fast, patient-specific DRM prediction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/swin-unetr-based-prediction-of-68-gagafapi-46-petct-dose-rate-maps-in-cancer-patients-quantitative-comparison-with-18-ffdg-petct/353372/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/swin-unetr-based-prediction-of-68-gagafapi-46-petct-dose-rate-maps-in-cancer-patients-quantitative-comparison-with-18-ffdg-petct/353372.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study?","Question",{"text":63,"@type":64},"To predict dose rate maps from [68Ga]Ga-FAPI-46 PET/CT using a deep-learning framework and quantitatively compare the dosimetric outputs with [18F]FDG PET/CT.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the dose rate maps generated and validated?",{"text":68,"@type":64},"PET/CT scans from 22 cancer patients were analyzed retrospectively; DRMs were generated using the dose voxel kernel (DVK) method in the GATE toolkit and compared against full Monte Carlo and other dosimetric approaches.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the paper conclude about [68Ga]Ga-FAPI-46 versus [18F]FDG?",{"text":72,"@type":64},"[68Ga]Ga-FAPI-46 shows higher tumor-to-background ratios, lower organ-at-risk uptake and absorbed doses, and better image contrast and lesion detectability; the Swin UNETR model enables fast, accurate DRM prediction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353372,1790153444,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Izadi-Yazdi et al. BMC Medical Imaging (2026) 26:401 BMC Medical Imaging  \n[https://doi.org/10.1186/s12880-026-02489-8](https://doi.org/10.1186/s12880-026-02489-8)  \nRESEARCH Open Access  \nSwin UNETR-based prediction of [68 Ga]GaFAPI-46 PET/CT dose rate maps in cancer patients: quantitative comparison with [ 18 F] FDG PET/CT  \nSaeideh Izadi-Yazdi 1, Farshid Babapour-Mofrad 1*, Elmira Yazdani2, Najme Karamzade-Ziarati3, Hossein Arabi4 and Mahdi Sadeghi2*  \nAbstract  \nBackground Fibroblast activation protein (FAP) is a promising theranostic target due to its high stroma expression in numerous malignancies. This study presents the first DL-based framework for predicting dose rate maps (DRMs) from [68Ga]Ga-FAPI-46 PET/CT, following a quantitative and dosimetric comparison with [ 18 F]FDG PET/CT. The approach supports personalized pre-therapeutic planning in radiopharmaceutical therapies (RPTs) .  \nMethods PET/CT scans with [68Ga]Ga-FAPI-46 and [ 18 F]FDG from 22 cancer patients were retrospectively analyzed. DRMs were generated using the dose voxel kernel (DVK) method using the GATE toolkit. Absorbed doses (ADs) obtained from DVK-based DRMs for tumors and organs at risk (OARs) were compared with those derived from  \nfull Monte Carlo (MC), and local energy deposition (LED), based DRMs, and organ-level estimates calculated using OLINDA/EXM v1 .1. Tracer uptake of [68Ga]Ga-FAPI-46 and [ 18 F]FDG was compared using SUVmax, SUVmean, and tumorto-background ratio (TBR) . A shifted windows UNEt TRansformers (Swin UNETR) model was trained to predict DRMsand benchmarked against ResNet-32 using R², RMSE, and gamma index.  \nResults [68Ga]Ga-FAPI-46 PET/CT demonstrated higher TBRs and lower OARs uptake and ADs compared to [ 18 F]FDG, indicating its promise in enhancing lesion detectability. The Swin UNETR model achieved an RMSE of 0.0598 Gy2/s, R2 of 0 . 960, and a gamma pass rate of 98 . 71%, outperforming ResNet-32 .  \nConclusion Compared to [ 18 F]FDG,[68Ga]Ga-FAPI-46 PET offers higher image contrast, better lesion detectability, and improved dosimetric profiles, supporting personalized RPT planning. While Swin UNETR enables fast and accurate DRM prediction from [68Ga]Ga-FAPI-46, broader validation in larger, multicenter cohorts is needed to ensure reproducibility and clinical impact.  \nKeywords Deep learning, Fibroblast activation protein (FAP), FAPI, Swin UNETR transformer, Dosimetry, Theranostics, Radiopharmaceutical therapy (RPT)  \n*Correspondence:  \nFarshid Babapour-Mofrad [babapour@iau.ac.ir](babapour@iau.ac.ir)[ ](babapour@iau.ac.ir)Mahdi Sadeghi[sadeghi.m@iums.ac.ir](sadeghi.m@iums.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nIzadi-Yazdi et al. BMC Medical Imaging (2026) 26:401  \nBackground  \nAdvancements in nuclear medicine have enabled the development of fibroblast activ","cbCaitL5VzdT4wDU","https://ap.wps.com/l/cbCaitL5VzdT4wDU","pdf",3041889,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To predict dose rate maps from [68Ga]Ga-FAPI-46 PET/CT using a deep-learning framework and quantitatively compare the dosimetric outputs with [18F]FDG PET/CT.\"},{\"question\":\"How were the dose rate maps generated and validated?\",\"answer\":\"PET/CT scans from 22 cancer patients were analyzed retrospectively; DRMs were generated using the dose voxel kernel (DVK) method in the GATE toolkit and compared against full Monte Carlo and other dosimetric approaches.\"},{\"question\":\"What does the paper conclude about [68Ga]Ga-FAPI-46 versus [18F]FDG?\",\"answer\":\"[68Ga]Ga-FAPI-46 shows higher tumor-to-background ratios, lower organ-at-risk uptake and absorbed doses, and better image contrast and lesion detectability; the Swin UNETR model enables fast, accurate DRM prediction.\"}]","Swin UNETR-based prediction of [68 Ga]GaFAPI-46 PET/CT dose rate maps in cancer patients - quantitative comparison with [18 F]FDG PET/CT | PDF",1790104970,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7ad1ddd67d758cf2ed39102930d535c.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d147a5bdf23cef0df235dd9d1592dae.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/803a0e5550f7f694db3443f889a7d2e9.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75ab14748c8a10a3869acef10c50d17d.webp",980,1306]